These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12743237)

  • 1. Natural history of cognitive decline in the old old.
    Howieson DB; Camicioli R; Quinn J; Silbert LC; Care B; Moore MM; Dame A; Sexton G; Kaye JA
    Neurology; 2003 May; 60(9):1489-94. PubMed ID: 12743237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the rate of cognitive decline in aging and early Alzheimer disease.
    Adak S; Illouz K; Gorman W; Tandon R; Zimmerman EA; Guariglia R; Moore MM; Kaye JA
    Neurology; 2004 Jul; 63(1):108-14. PubMed ID: 15249619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype and lifetime cognitive decline.
    Kozauer NA; Mielke MM; Chan GK; Rebok GW; Lyketsos CG
    Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.
    DeCarli C; Mungas D; Harvey D; Reed B; Weiner M; Chui H; Jagust W
    Neurology; 2004 Jul; 63(2):220-7. PubMed ID: 15277612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.
    Payami H; Grimslid H; Oken B; Camicioli R; Sexton G; Dame A; Howieson D; Kaye J
    Am J Hum Genet; 1997 Apr; 60(4):948-56. PubMed ID: 9106542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.
    Kang JH; Weuve J; Grodstein F
    Neurology; 2004 Jul; 63(1):101-7. PubMed ID: 15249618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of clinical and neuropsychologic information as a better predictor of the progression to Alzheimer disease in questionable dementia individuals.
    Lee DY; Youn JC; Choo IH; Kim KW; Jhoo JH; Pak YS; Suh KW; Woo JI
    Am J Geriatr Psychiatry; 2006 Feb; 14(2):130-8. PubMed ID: 16473977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.
    Soldan A; Pettigrew C; Cai Q; Wang MC; Moghekar AR; O'Brien RJ; Selnes OA; Albert MS;
    JAMA Neurol; 2016 Jun; 73(6):698-705. PubMed ID: 27064267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein epsilon4 allele and problems with orientation are associated with a persistent decline in cognition in community-dwelling elderly persons.
    Wayne SJ; Vellas BJ; Brodie SG; Garry PJ; Baumgartner RN
    J Gerontol A Biol Sci Med Sci; 2005 Mar; 60(3):375-9. PubMed ID: 15860477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment represents early-stage Alzheimer disease.
    Morris JC; Storandt M; Miller JP; McKeel DW; Price JL; Rubin EH; Berg L
    Arch Neurol; 2001 Mar; 58(3):397-405. PubMed ID: 11255443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
    Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
    Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Cognitive and Functional Decline in Patients With Alzheimer Disease Dementia From Brazil.
    Oliveira FF; Chen ES; Smith MC; Bertolucci PH
    Alzheimer Dis Assoc Disord; 2016; 30(3):243-50. PubMed ID: 26523709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does elevated parathyroid hormone concentration predict cognitive decline in older people?
    Björkman MP; Sorva AJ; Tilvis RS
    Aging Clin Exp Res; 2010 Apr; 22(2):164-9. PubMed ID: 19934619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.